Association of sputum parameters with clinical and functional measurements in asthma

Thorax

Volumn 55, Issue 3, 2000, Pages 235-238

  Rosi, Elisabetta ^a   Scano, Giorgio ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MONTELUKAST; PEPTIDOLEUKOTRIENE; PREDNISONE; PROSTAGLANDIN E2; THEOPHYLLINE;

ASTHMA; BRONCHUS REACTIVITY; CYTOLOGY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SHORT SURVEY; SPUTUM ANALYSIS; T LYMPHOCYTE;

ALBUTEROL; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; FORCED EXPIRATORY VOLUME; HUMANS; PREDNISOLONE; SPUTUM; VITAL CAPACITY;

EID: 0034012913     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.3.235     Document Type: Short Survey

References (46)

1. 1 Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
2. 2 National Heart, Lung, and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992;5:601-41.
3. 3 Gibson PJ, Girgis-Gabardo A, Morris MM, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989;44:693-9.
4. 4 Pin I, Gibson PG, Kolendowicz R, et al. Use of sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
5. 5 Fahy JV, Liu J, Wong H, et al. Cellular and biochemical analysis of induced sputum from asthmatics and from healthy subjects. Am Rev Respir Dis 1993;147:1126-31.
6. 6 in't Veen JCCM, de Grouw HWFM, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996;9:2441-7.
7. 7 Spanevello A, Migliori GB, Sharara A, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997;27:1138-44.
8. 8 Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-17.
9. 9 Virchow JC Jr, Holscher V, Virchow C. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992;146:604-6.
10. 10 Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Measuring airway inflammation in asthma; eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997;99:539-44.
11. 11 Keatings VM, O'Connor BJ, Wright LG, et al. Late response to allergen is associated with increased concentration of sputum tumor necrosis factor-alpha and IL-5 in induced sputum. J Allergy Clin Immunol 1997;5:693-8.
12. 12 Turner MO, Hussack P, Sears MR, et al. Exacerbation of asthma without eosinophilia. Thorax 1995;50:1057-61.
13. 13 Ronchi MC, Piragino C, Rosi E, et al. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J 1997;10:1809-13.
14. 14 Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Ant J Respir Crit Care Med 1998;157:4-9.
15. 15 Lim S, Jatakanon A, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999;159:22-30.
16. 16 Grootendorst DC, van den Bos JW, Romeijn JJ, et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J 1999;13: 647-53.
17. 17 Rosi E, Ronchi MC, Grazzini M, et al. Sputum analysis, bronchial hyperresponsiveness and pulmonary function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999;103:232-7.
18. 18 Jatakanon A, Lim S, Kharitonov A, et al. Correlation between exhaled nitric oxide, sputum cosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-5.
19. 19 Claman DM, Boushey HA, Liu J, et al. Analysis of induced sputum to examine the effect of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994;94:861-9.
20. 20 Foresi A, Leone C, Pelucchi A, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997;100:58-64.
21. 21 Grunberg K, Smits HH, Timmers MC, et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-16.
22. 22 Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses Am Rev Respir Dis 1992;145:1265-9.
23. 23 Shi HZ, Deng JM, Xu H, et al. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998;157:1818-21.
24. 24 Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998;157:204-9.
25. 25 Sulakvelidze I, Inman MD, Rerecich T, et al. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998;11:821-7.
26. 26 Gibson PG, Wlodarczyk JW, Hensley MJ, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998;158:36-41.
27. 27 Iredale MJ, Wanklyn SAR, Phillips IP, et al. Noninvasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hyperronic saline. Clin Exp Allergy 1994;24:940-5.
28. 28 Brusasco V, Crimi E, Barisione G, et al. Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation. J Appl Physiol 1999;87:567-73.
29. 29 Pacini F, Filippelli M, Duranti R, et al. Reduction in bronchodilation following a deep inhalation is poorly related to airway inflammation in asthma. Eur Respir J (in press).
30. 30 Polosa R, Renaud L, Cacciola R, et al. Sputum cosinophilia is more closely associated with airway responsiveness to bradykinin than methacholine in asthma Eur Respir J 1998; 12:551-6.
31. 31 Fujimoto K, Kubo K, Matsuzawa Y, et al. Eosinophil cationic protein levels in induced sputum correlate with the seventy of bronchial asthma. Chest 1997;112:1241-7.
32. 32 In't Veen JCCM, Smits HH, Ravensberg AJJ, et al. Impaired perception of dyspnea in patients with severe asthma: relation to sputum eosinophils. Am J Respir Crit Care Med 1998;158:1134-41.
33. 33 Pizzichini MMM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbation of asthma. Kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997;155:1501-8.
34. 34 Fahy JV, Boushey HA. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998;11:1240-7.
35. 35 Wardlaw AJ, Dunnette S, Gleich GJ, et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
36. 36 Kirby JG, Hargreave FE, Gleich GJ, et al. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987;136:379-83.
37. 37 Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995;96:2339-2340.
38. 38 Pare PD, Wiggs BR, James A, et al. The comparative mechanics and morphology of airways in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1189-93.
39. 39 Pare PD, Roberts CR, Bai TR, et al. The functional consequences of airway remodelling in asthma. Monaldi Arch Chest Dis 1997;52:586-96.
40. 40 Roisman GL, Peiffer C, Lacronique JG, et al. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 1995;96:12-21.
41. 41 Higgs CMB, Laszlo G. Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma. Clin Sci 1996;90:227-34.
42. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999;159: 31-6.
43. 43 Minoguchi K, Kohno Y, Oda N, et al. Effect of theophilline withdrawal on airway inflammation in asthma. Clin Exp Allergy 1998;28:57-63.
44. 44 O'Byrne PM, Manning PJ. Clinical relevance of lipid mediators in asthma. J Asthma 1992;29:153-63.
45. 45 Mulder A, Gauvreau GM, Watson RM, et al. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1999;159:1562-7.
46. 46 Diamant Z, Grootendorst DC, Veselic-Charvat M, et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999;29:42-51.